Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 35 min ago
Peer-reviewedLicence not statedInternational Journal of MS Care

Mediating and Moderating Factors of the Effect of Psychological Therapies Among People With Multiple Sclerosis

10 affiliations
  1. 1Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada
  2. 2St Michael’s Hospital, Toronto, ON, Canada
  3. 3Rehabilitation Sciences Institute, University of Toronto, Toronto, ON, Canada
  4. 4Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada Rehabilitation Sciences Institute, University of Toronto, Toronto, ON, Canada
  5. 5McMaster University, Hamilton, ON, Canada
  6. 6School of Rehabilitation Science, University of Saskatchewan, Saskatoon, SK, Canada
  7. 7Department of Physical Medicine and Rehabilitation, University of Saskatchewan, Saskatoon, SK, Canada
  8. 8St Michael’s Hospital, Toronto, ON, Canada Department of Medicine, University of Toronto, Toronto, ON, Canada
  9. 9Ottawa Hospital Research Institute, Ottawa, ON, Canada University of Ottawa Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada
  10. 10Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada St Michael’s Hospital, Toronto, ON, Canada

Related

  1. Adverse childhood experiences and cyber aggression among college students: the mediating role of psychological resilience and the moderating role of physical exercise.
    Luyao Xiang, Hao Gou, Qunqun Sun +2
    Frontiers in psychiatryPeer-reviewedCC BYFull text2 citedPsychiatry & mental healthEurope PMC
  2. DELPHI expert consensus-derived factors influencing the early use of monoclonal high-efficacy therapies in treatment-naïve patients with relapsing-remitting multiple sclerosis.
    Bertrand Bourre, Olivier Guerrier, Xavier Ayrignac +7
    Journal of neurologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Virus-specific effects of disease-modifying therapies on herpesvirus antibody titers in multiple sclerosis
    Stefano Ruberto, María I. Domínguez-Mozo, Luisa María Villar +13
    Scientific ReportsPeer-reviewedCC BY 4.0Full textGeneral medicineCrossref
  4. Disease-modifying therapies (DMTs) discontinuation in older relapsing-remitting multiple sclerosis (RRMS) patients with stable disease: Two-year randomized, controlled trial.
    Sajjad Daneshyar, Masoud Ghiasian, Salman Khazaei +2
    Caspian journal of internal medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Fifteen-year real-world pharmacovigilance of multiple sclerosis disease-modifying therapies: adverse event profiles, drug-specific safety signals and clinical implications
    Sen Lin, Bei Zhang, Yingzhao Zhang +4
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefPMC
BibTeX
@article{feng2026mediating,
  title = {{Mediating and Moderating Factors of the Effect of Psychological Therapies Among People With Multiple Sclerosis}},
  author = {Gregory Feng and Laura Kathleen Langer and Jillian Scandiffio and Ashvene Sureshkumar and Vjura Senthilnathan and Michelle Bromberg and Sarah Donkers and Katherine Knox and Tania Bruno and Lisa A.S. Walker and Mark Bayley and Robert Simpson},
  journal = {International Journal of MS Care},
  year = {2026},
  month = sep,
  doi = {10.7224/1537-2073.2025-095},
  url = {https://doi.org/10.7224/1537-2073.2025-095},
}
RIS
TY  - JOUR
TI  - Mediating and Moderating Factors of the Effect of Psychological Therapies Among People With Multiple Sclerosis
AU  - Gregory Feng
AU  - Laura Kathleen Langer
AU  - Jillian Scandiffio
AU  - Ashvene Sureshkumar
AU  - Vjura Senthilnathan
AU  - Michelle Bromberg
AU  - Sarah Donkers
AU  - Katherine Knox
AU  - Tania Bruno
AU  - Lisa A.S. Walker
AU  - Mark Bayley
AU  - Robert Simpson
PY  - 2026
DA  - 2026/09/14
JO  - International Journal of MS Care
DO  - 10.7224/1537-2073.2025-095
UR  - https://doi.org/10.7224/1537-2073.2025-095
SN  - 1537-2073
SN  - 2834-5398
ER  -